60,755
As of 2022, there were 60,755 community pharmacies across the United States, which included 37,954 (61.5%) chains, 23,521 (38.1%) regional franchises or independently owned pharmacies, and 240 (0.4%) government pharmacies. (Berenbrok 2022)
76.5
%
Within rural areas, 76.5% of pharmacies were regionally owned franchises or independently owned pharmacies. For those in larger metropolitan areas, 62.8% of pharmacies were chain locations. (Berenbrok 2022)
38
As of July 2026, pharmacists in 38 states can furnish HIV PrEP/PEP. Of those, in 23 states, pharmacists can provide PrEP and PEP, whereas in 4 states, pharmacists can provide PEP. In 9 states, a pharmacist can provide PrEP/PEP with prescriber collaboration such as collaborative practice agreement or standing order or statewide protocol; 4 states allow pharmacists to provide PEP with prescriber collaboration.
15.1
%
There are 15.1% more pharmacy locations within low-income communities than physician practices, and they offer 95.7% more operating hours than physician practices sites. (Popovian 2022)
2
x
Patients visit their pharmacy and their pharmacists twice as often as they visit their physician’s office and their primary care provider. (Valliant 2022, Berenbrok 2020)
34
As of October 2024, 34 states and D.C. authorize pharmacists to prescribe hormonal contraception. Pharmacists are permitted to prescribe oral contraception in all of these states and, in some states, may prescribe other contraception types. State scopes vary in their requirements for prescriptive authority and may require collaborative practice agreements, standing orders, or statewide protocols, and may also include age requirements, length of supply, and whether a patient needs a prior prescription from a physician.
89
%
As of 2022, 89% of Americans live within five miles of a pharmacy and a pharmacist. (Berenbrok 2022)
11
As of November 2024, pharmacists in 11 states can conduct test and treat for minor ailments (vary by state but may include, and are not limited to, influenza, group A streptococcus pharyngitis, COVID-19, RSV, lice, and skin conditions of ringworm and athlete’s foot) via prescriptive authority or statewide protocol.
22
As of November 2024, pharmacists in 22 states with some variability can test and treat for COVID-19, influenza, RSV, or strep via prescriptive authority, statewide protocol, or other means that are limited to collaborative practice agreements or prescriber protocols that allow multiple patients and do not require past prescriber–patient relationship.